United Kingdom

People: CareDx Inc (CDNA.OQ)

CDNA.OQ on NASDAQ Stock Exchange Global Market

7:22pm BST
Change (% chg)

$-0.69 (-2.12%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Maag, Peter 

Dr. Peter Maag, Ph.D. is Chief Executive Officer and Director of the Company. Dr. Maag has served as our Chief Executive Officer since October 2012 and as a member of our Board of Directors since November 2012. Dr. Maag also served as our President from October 2012 until November 2018. Prior to joining the Company, Dr. Maag held numerous positions with increasing responsibility at Novartis International AG, a global healthcare company from September 2001 to April 2012, including Global Head of Novartis Diagnostics, a business unit of Novartis A.G., from 2009 to 2012. Dr. Maag also served as Country President for Novartis Pharma AG in Germany from 2006 to 2008, Country President for Novartis’ Korea operations from 2003 to 2005, and the Head of Strategy for the pharmaceutical division of Novartis A.G. from 2001 to 2002. Dr. Maag also worked at McKinsey & Company, focusing on healthcare and globalization from 1995 to 2001. Besides supporting various healthcare and tech companies in their growth efforts, Dr. Maag also holds a board position at Phoenix Pharma SE and serves on the board of Personalized Medicine Coalition in Washington D.C. Dr. Maag studied pharmaceutical sciences at the University of Heidelberg and University of London and received his Ph.D. from the University of Berlin, Germany.

Basic Compensation

Total Annual Compensation, USD 483,750
Restricted Stock Award, USD 2,728,320
Long-Term Incentive Plans, USD --
All Other, USD 2,019,320
Fiscal Year Total, USD 5,231,390

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Goldberg


Reginald Seeto


Peter Maag


Michael Bell


Sasha King


James Yee

As Of  31 Dec 2018